Titre : Version foetale

Version foetale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neonatal Screening
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Version foetale : Questions médicales les plus fréquentes", "headline": "Version foetale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Version foetale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Version foetale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Accouchement (procédure)", "url": "https://questionsmedicales.fr/mesh/D036861", "about": { "@type": "MedicalCondition", "name": "Accouchement (procédure)", "code": { "@type": "MedicalCode", "code": "D036861", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E04.520.252" } } }, "about": { "@type": "MedicalCondition", "name": "Version foetale", "alternateName": "Version, Fetal", "code": { "@type": "MedicalCode", "code": "D014710", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "You Jung Han", "url": "https://questionsmedicales.fr/author/You%20Jung%20Han", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea." } }, { "@type": "Person", "name": "Jin Hoon Chung", "url": "https://questionsmedicales.fr/author/Jin%20Hoon%20Chung", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea." } }, { "@type": "Person", "name": "Moon Young Kim", "url": "https://questionsmedicales.fr/author/Moon%20Young%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea." } }, { "@type": "Person", "name": "Min Hyoung Kim", "url": "https://questionsmedicales.fr/author/Min%20Hyoung%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Gangseo Mizmedi Hospital, Seoul, Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Retinopathy of Prematurity Outcomes of Neonates Meeting Only a Single Screening Criterion: Proposal of the TWO-ROP Algorithm.", "datePublished": "2023-03-17", "url": "https://questionsmedicales.fr/article/36933856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.03.007" } }, { "@type": "ScholarlyArticle", "name": "Feasibility and acceptability of home-based neonatal hyperbilirubinemia screening by community health workers using transcutaneous bilimeters in Bangladesh.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37009866", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-023-03969-4" } }, { "@type": "ScholarlyArticle", "name": "A \"twelve-section ultrasonic screening and diagnosis method\" and management system for screening and treating neonatal congenital heart disease at the grassroots level in Tang County, Hebei Province, China.", "datePublished": "2024-05-15", "url": "https://questionsmedicales.fr/article/38750445", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12884-024-06569-x" } }, { "@type": "ScholarlyArticle", "name": "Use of Portable Automated Auditory Brainstem Responses in Universal Neonatal Hearing Screening: A Mixed-Method Study in Odisha, India.", "datePublished": "2023-01-04", "url": "https://questionsmedicales.fr/article/36598633", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12098-022-04435-2" } }, { "@type": "ScholarlyArticle", "name": "Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.", "datePublished": "2022-09-15", "url": "https://questionsmedicales.fr/article/36189201", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.999664" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Procédures de chirurgie opératoire", "item": "https://questionsmedicales.fr/mesh/D013514" }, { "@type": "ListItem", "position": 3, "name": "Procédures de chirurgie obstétrique", "item": "https://questionsmedicales.fr/mesh/D013513" }, { "@type": "ListItem", "position": 4, "name": "Accouchement (procédure)", "item": "https://questionsmedicales.fr/mesh/D036861" }, { "@type": "ListItem", "position": 5, "name": "Version foetale", "item": "https://questionsmedicales.fr/mesh/D014710" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Version foetale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Version foetale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Version foetale", "description": "Comment diagnostiquer une présentation en siège ?\nQuels signes indiquent une version fœtale ?\nQuand effectuer une échographie pour la version fœtale ?\nQuels examens préalables à la version fœtale ?\nPeut-on détecter une version fœtale par palpation ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Version foetale", "description": "Quels symptômes peuvent indiquer un siège fœtal ?\nY a-t-il des douleurs associées à la version fœtale ?\nComment se manifeste un fœtus en siège ?\nQuels signes de détresse fœtale peuvent apparaître ?\nLes contractions sont-elles différentes en cas de siège ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Version foetale", "description": "Peut-on prévenir un siège fœtal ?\nLes exercices peuvent-ils aider à la position fœtale ?\nLe yoga peut-il influencer la position fœtale ?\nLes positions de sommeil affectent-elles la version ?\nLes visites régulières chez le médecin sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Version foetale", "description": "Comment se déroule une version fœtale ?\nQuels sont les risques de la version fœtale ?\nQuand est-il préférable de ne pas faire de version fœtale ?\nQuels médicaments peuvent être utilisés lors de la version ?\nLa version fœtale est-elle toujours efficace ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Version foetale", "description": "Quelles complications peuvent survenir après une version ?\nLa version fœtale peut-elle entraîner une césarienne ?\nQuels sont les signes d'une complication post-version ?\nLes complications sont-elles fréquentes après une version ?\nComment gérer les complications après une version ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Version foetale", "description": "Quels facteurs augmentent le risque de siège fœtal ?\nL'âge maternel influence-t-il la position fœtale ?\nLes anomalies utérines affectent-elles la version fœtale ?\nLe tabagisme maternel influence-t-il la position fœtale ?\nLes antécédents de césarienne influencent-ils la version ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une présentation en siège ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie et l'examen pelvien permettent de confirmer la présentation en siège." } }, { "@type": "Question", "name": "Quels signes indiquent une version fœtale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Une palpation abdominale révèle la position du fœtus et des mouvements anormaux." } }, { "@type": "Question", "name": "Quand effectuer une échographie pour la version fœtale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une échographie est recommandée vers la 36e semaine de grossesse pour évaluer la position." } }, { "@type": "Question", "name": "Quels examens préalables à la version fœtale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un examen clinique et une échographie sont nécessaires pour évaluer les risques." } }, { "@type": "Question", "name": "Peut-on détecter une version fœtale par palpation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la palpation abdominale permet d'évaluer la position du fœtus." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un siège fœtal ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une sensation de pression dans le bas-ventre et des mouvements fœtaux anormaux." } }, { "@type": "Question", "name": "Y a-t-il des douleurs associées à la version fœtale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales peuvent survenir lors de la manœuvre de version." } }, { "@type": "Question", "name": "Comment se manifeste un fœtus en siège ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Le fœtus en siège peut provoquer des douleurs lombaires et une pression pelvienne." } }, { "@type": "Question", "name": "Quels signes de détresse fœtale peuvent apparaître ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution des mouvements fœtaux ou des anomalies du rythme cardiaque." } }, { "@type": "Question", "name": "Les contractions sont-elles différentes en cas de siège ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les contractions peuvent être plus intenses et moins régulières avec un fœtus en siège." } }, { "@type": "Question", "name": "Peut-on prévenir un siège fœtal ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode garantie pour prévenir un siège fœtal, mais un suivi régulier aide." } }, { "@type": "Question", "name": "Les exercices peuvent-ils aider à la position fœtale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certains exercices de positionnement peuvent encourager le fœtus à se retourner." } }, { "@type": "Question", "name": "Le yoga peut-il influencer la position fœtale ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le yoga prénatal peut aider à améliorer la flexibilité et favoriser une meilleure position." } }, { "@type": "Question", "name": "Les positions de sommeil affectent-elles la version ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Dormir sur le côté gauche peut favoriser une meilleure circulation et position fœtale." } }, { "@type": "Question", "name": "Les visites régulières chez le médecin sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de surveiller la position fœtale et d'anticiper les complications." } }, { "@type": "Question", "name": "Comment se déroule une version fœtale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La version fœtale est réalisée par un obstétricien, souvent sous échographie et anesthésie." } }, { "@type": "Question", "name": "Quels sont les risques de la version fœtale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent la rupture des membranes, la détresse fœtale et des saignements." } }, { "@type": "Question", "name": "Quand est-il préférable de ne pas faire de version fœtale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "En cas de placenta praevia, de malformations fœtales ou de complications maternelles." } }, { "@type": "Question", "name": "Quels médicaments peuvent être utilisés lors de la version ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des tocolytiques peuvent être administrés pour détendre l'utérus pendant la manœuvre." } }, { "@type": "Question", "name": "La version fœtale est-elle toujours efficace ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La version fœtale réussit dans environ 50-70% des cas, selon la situation clinique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une version ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements, des contractions prématurées ou une détresse fœtale peuvent survenir." } }, { "@type": "Question", "name": "La version fœtale peut-elle entraîner une césarienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, si la version échoue ou si des complications surviennent, une césarienne peut être nécessaire." } }, { "@type": "Question", "name": "Quels sont les signes d'une complication post-version ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales intenses, des saignements ou une diminution des mouvements fœtaux." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes après une version ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares, mais un suivi médical est essentiel après la procédure." } }, { "@type": "Question", "name": "Comment gérer les complications après une version ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical étroit et des interventions appropriées sont nécessaires pour gérer les complications." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de siège fœtal ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les grossesses multiples, l'anatomie pelvienne et les antécédents de siège augmentent le risque." } }, { "@type": "Question", "name": "L'âge maternel influence-t-il la position fœtale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes plus âgées peuvent avoir un risque accru de présentation en siège." } }, { "@type": "Question", "name": "Les anomalies utérines affectent-elles la version fœtale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anomalies utérines peuvent limiter la capacité du fœtus à se positionner correctement." } }, { "@type": "Question", "name": "Le tabagisme maternel influence-t-il la position fœtale ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affecter le développement fœtal et augmenter le risque de siège." } }, { "@type": "Question", "name": "Les antécédents de césarienne influencent-ils la version ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents de césarienne peuvent compliquer la version fœtale et augmenter les risques." } } ] } ] }

Sources (10000 au total)

Retinopathy of Prematurity Outcomes of Neonates Meeting Only a Single Screening Criterion: Proposal of the TWO-ROP Algorithm.

To assess the rates of retinopathy of prematurity (ROP) and treatment-warranted ROP in a modern set of patients meeting 0 or 1 of the current ROP screening criteria.... Retrospective cohort study.... Single-center study of 9350 infants screened for ROP from 2009 to 2019. Rates of ROP and treatment-warranted ROP were evaluated in group 1 (birth weight [BW] <1500 g and gestational age [GA] ≥30 weeks... Of 7520 patients with reported BW and GA, 1612 (21.4%) patients met the inclusion criteria. The number of patients in groups 1, 2, and 3 was 466 (6.19%), 23 (0.31%), and 1123 (14.93%), respectively. T... Patients meeting 1 screening criterion had a low rate of ROP (<5%), with no stage 3, zone 1, or plus disease. No patients required treatment. We propose a possible algorithm (TWO-ROP) in appropriate n...

Feasibility and acceptability of home-based neonatal hyperbilirubinemia screening by community health workers using transcutaneous bilimeters in Bangladesh.

Universal screening for neonatal hyperbilirubinemia risk assessment is recommended by the American Academy of Pediatrics to reduce related morbidity. In Bangladesh and in many low- and middle-income c... We employed a two-step process. In the formative phase, we conducted eight focus group discussions with parents and grandparents of infants and eight key informant interviews with public and private h... Formative findings identified misconceptions regarding neonatal hyperbilirubinemia causes and health risks among caregivers in rural Bangladesh. CHWs were comfortable with adoption, maintenance and us... Adopting household neonatal hyperbilirubinemia screening in the postnatal period by CHWs using a transcutaneous bilimeter is an acceptable approach by both CHWs and families and may increase rates of ...

A "twelve-section ultrasonic screening and diagnosis method" and management system for screening and treating neonatal congenital heart disease at the grassroots level in Tang County, Hebei Province, China.

To explore a method for screening and diagnosing neonatal congenital heart disease (CHD) applicable to grassroots level, evaluate the prevalence of CHD, and establish a hierarchical management system ... A total of 24,253 newborns born in Tang County between January 2016 and December 2020 were consecutively enrolled and screened by trained primary physicians via the "twelve-section ultrasonic screenin... The centre confirmed that, except for 2 newborns with patent ductus arteriosus missed in the diagnosis of ventricular septal defect combined with severe pulmonary hypertension, newborns with other iso... The "twelve-section method" is suitable for screening neonatal CHD at the grassroots level. The establishment of a hierarchical management system for CHD screening and treatment is conducive to the sc...

Incidence of Neonatal Developmental Dysplasia of the Hip and Late Detection Rates Based on Screening Strategy: A Systematic Review and Meta-analysis.

Universal ultrasonographic screening for developmental dysplasia of the hip (DDH) has gained increasing popularity despite the lack of benefit in terms of reducing the rates of late-detected cases (ag... To report the reported incidence of DDH in the English scientific literature and compare rates of late-detected cases in settings with different DDH screening strategies.... PubMed, Scopus, and Web of Science databases were searched on November 25 and 27, 2021. No time filters were used in the search.... All observational studies reporting the incidence of early-detected or late-detected (age ≥12 weeks) DDH were included. Non-English reports were excluded if the abstract did not include enough informa... The number of newborns screened and the detection rates were extracted. Meta-analysis calculated the pooled incidence of DDH per 1000 newborns with 95% CIs using a random- or fixed-effects model. This... The main outcome measures were early detection, early treatment, late detection, and operative treatment incidences.... A total of 1899 studies were identified, 203 full texts were assessed, and 76 studies with 16 901 079 infants were included in final analyses. The early detection rate was 8.4 (95% CI, 4.8-14.8) infan... This meta-analysis found that early detection rates and nonoperative treatments were higher with universal screening. The late detection and operative treatment rates with universal screening were sim...

Community health worker-led household screening and management of neonatal hyperbilirubinemia in rural Bangladesh: a cluster randomized control trial protocol.

Extreme hyperbilirubinemia leading to neurologic disability and death is disproportionately higher in low- and middle-income countries (LMIC) such as Bangladesh, and is largely preventable through tim... 530 Bangladeshi women in their second or third trimester of pregnancy from the rural community of Sakhipur, Bangladesh will be recruited for a cluster randomized trial and randomized to the interventi... This study will evaluate the effectiveness of CHW-led home phototherapy to increase neonatal hyperbilirubinemia treatment rates in rural Bangladesh. LMICs are expanding access to postnatal care by usi...

Main outcomes from the first 2 years of France's screening programme for neonatal permanent hearing loss through a descriptive study.

This study aimed to evaluate the implementation of France's neonatal hearing loss screening programme years after its launch, and to estimate permanent bilateral neonatal hearing loss (PBNHL) prevalen... This descriptive study used aggregated regional data on all births in France in 2015-2016. Screening coverage, refusal rate, positive predictive value (PPV), proportion of children with suspected PBNH... Eight hundred thousand neonates were eligible for the screening programme per year. Between 2015 and 2016, screening coverage increased (83.3% vs. 93.8%; p < 0.001), and the refusal rate remained stab... The national target of 90% screening coverage was exceeded. The additional test could be useful to avoid overcrowding in diagnostic structures. Diagnostic data quality must be improved to confirm PBNH...

Association Between Expanded Genomic Sequencing Combined With Hearing Screening and Detection of Hearing Loss Among Newborns in a Neonatal Intensive Care Unit.

Hearing loss is a global social burden. Early identification of hearing loss missed by newborn hearing screening tests in the neonatal intensive care unit is crucial.... To assess the association between expanded genomic sequencing combined with hearing screening and detection of hearing loss as well as improvement in the neonatal intensive care unit.... This cohort study was performed between August 8, 2016, and December 31, 2020, among 8078 newborns admitted to the neonatal intensive care unit of the Children's Hospital of Fudan University in Shangh... A hearing screening test and the expanded genomic sequencing targeting 2742 genes were administered to each patient. Those who failed the hearing screening test or had positive genetic findings were r... The primary outcome was hearing loss missed by hearing screening test. Secondary outcomes were genetic findings and benefits associated with the expanded genomic sequencing for clinical management of ... Of 8078 patients (4666 boys [57.8%]; median age, 6.3 days [IQR, 3.0-12.0 days]), 52 of 240 (21.7%) received a diagnosis of hearing loss. Expanded genomic sequencing combined with hearing screening was... This study suggests that expanded genomic sequencing combined with hearing screening may be effective at detecting hearing loss among patients in the neonatal intensive care unit....

Harmonization of distributed multi-center analysis based on dried blood spot reference materials supporting the screening of neonatal inherited metabolic disorders.

The standardization of quantification data is critical for ensuring the reliability and measurement traceability in the screening of neonatal inherited metabolic disorders. However, the availability o... In this study, we developed a series of dried blood spot (DBS) reference materials containing 9 amino acids (AA) and 10 acylcarnitines (AC) for neonatal screening. Four levels of the reference materia... We found high homogeneity and stability at all levels of the reference materials, with the coefficient of variation (CV) of the analytes less than 15%. These reference materials can be used to assess ... The DBS reference materials proposed in this study provide reliability for the harmonization in multi-center analysis for the screening of neonatal inherited metabolic disorders. And applying our corr...